Koromina M, Pandi MT, van der Spek PJ, Patrinos GP, Lauschke VM. The ethnogeographic variability of genetic factors underlying G6PD deficiency. Pharmacol Res. 2021;173: 105904.

Article  CAS  PubMed  Google Scholar 

Snyder LH. Inherited taste deficiency. Science. 1910;1931(74):151–2.

Google Scholar 

Motulsky AG. Drug reactions, enzymes, and biochemical genetics. J Am Med Assoc. 1957;165(7):835–7.

Article  CAS  PubMed  Google Scholar 

Vogel F. Moderne Probleme der Humangenetik. Ergeb Inn Med Kinderheilkund. 1959;12:52–125.

Google Scholar 

Knight RA, Selin MJ, Harris HW. Genetic factors influencing isoniazid blood levels in humans. Trans Conf Chemother Tuberc. 1959;8:52–6.

Google Scholar 

Harada S, Agarwal DP, Goedde HW. Isozyme variations in acetaldehyde dehydrogenase (e.c.1.2.1.3) in human tissues. Hum Genet. 1978;44(2):181–5.

Article  CAS  PubMed  Google Scholar 

Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol. 1979;16(3):183–7.

Article  CAS  PubMed  Google Scholar 

Mahgoub A, Dring LG, Idle JR, Lancaster R, Smith RL. Polymorphic hydroxylation of debrisoquine in man. Lancet. 1977;2(8038):584–6.

Article  CAS  PubMed  Google Scholar 

Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988;331(6155):442–6.

Article  CAS  PubMed  Google Scholar 

Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 1990;9(3):193–203.

Article  CAS  PubMed  Google Scholar 

Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM. Integrating rare genetic variants into pharmacogenetic drug response predictions. Hum Genomics. 2018;12(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, et al. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med. 2018;20(6):622–9.

Article  CAS  PubMed  Google Scholar 

Chan HT, Chin YM, Low S-K. The roles of common variation and somatic mutation in cancer pharmacogenomics. Oncol Ther. 2019;7(1):1–32.

Article  PubMed  PubMed Central  Google Scholar 

Filipski KK, Mechanic LE, Long R, Freedman AN. Pharmacogenomics in oncology care. Front Genet. 2014;5:73.

Article  PubMed  PubMed Central  Google Scholar 

Luczak T, Brown SJ, Armbruster D, Hundertmark M, Brown J, Stenehjem D. Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs. Pharmacogenomics. 2021;22(6):345–64.

Article  CAS  PubMed  Google Scholar 

US Food and Drug Administration. 2023. https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations#section1. Accessed 8 Nov 2023.

US Food and Drug Administration. 2023. https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations#section3. Accessed 8 Nov 2023.

Kirsch I. Placebo Effect in the Treatment of Depression and Anxiety. Front Psychiatry. 2019;10:407.

Article  PubMed  PubMed Central  Google Scholar 

Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):601.

Article  PubMed  PubMed Central  Google Scholar 

Lauschke VM, Ingelman-Sundberg M. Prediction of drug response and adverse drug reactions: from twin studies to next generation sequencing. Eur J Pharm Sci. 2019;130:65–77.

Article  CAS  PubMed  Google Scholar 

Curtis D. The PREPARE study: benefits of pharmacogenetic testing are unclear. Lancet. 2023;401(10391):1850–1.

Article  PubMed  Google Scholar 

Damkier P, Andersen MA. Temporary like achilles: pre-emptive germline pharmacogenetic testing. Basic Clin Pharmacol Toxicol. 2023;133(4):397–9.

Article  PubMed  Google Scholar 

van der Lee M, Rowell WJ, Menafra R, Guchelaar H-J, Swen JJ, Anvar SY. Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle. Pharmacogenomics J. 2022;22(1):75–81.

Article  PubMed  Google Scholar 

Liu C, Yang X, Duffy BF, Hoisington-Lopez J, Crosby M, Porche-Sorbet R, et al. High-resolution HLA typing by long reads from the R10.3 Oxford nanopore flow cells. Hum Immunol. 2021;82(4):288–95.

Article  CAS  PubMed  Google Scholar 

Chin C-S, Khalak A. Human genome assembly in 100 minutes. BioRxiv. 2019;705616.

Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson D, Wilke MAP, Lyle SM, Kowalec K, Jorgensen A, Wright GEB, et al. A Systematic review and analysis of the use of polygenic scores in pharmacogenomics. Clin Pharmacol Ther. 2022;111(4):919–30.

Article  PubMed  Google Scholar 

Koido M, Kawakami E, Fukumura J, Noguchi Y, Ohori M, Nio Y, et al. Polygenic architecture informs potential vulnerability to drug-induced liver injury. Nat Med. 2020;26(10):1541–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai S, Zhang H, Mehrotra DV, Shen J. Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods. Nat Commun. 2022;13(1):5278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Yoshikawa A, Brennan MD, Ramsey TL, Meltzer HY. Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes. Schizophr Res. 2018;192:194–204.

Article  PubMed  Google Scholar 

Lanfear DE, Luzum JA, She R, Li J, Sabbah HN, Zeld N, et al. Validation of a polygenic score for beta-blocker survival benefit in patients with heart failure using the United Kingdom biobank. Circ Genom Precis Med. 2023;16(2): e003835.

Article  PubMed  Google Scholar 

Zhou Y, Lauschke VM. Computational tools to assess the functional consequences of rare and noncoding pharmacogenetic variability. Clin Pharmacol Ther. 2021;110(3):626–36.

Article  PubMed  Google Scholar 

Zhou Y, Mkrtchian S, Kumondai M, Hiratsuka M, Lauschke VM. An optimized prediction framework to assess the functional impact of pharmacogenetic variants. Pharmacogenomics J. 2019;19(2):115–26.

Article  CAS  PubMed  Google Scholar 

Lauschke VM, Ingelman-Sundberg M. Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation. NPJ Genom Med. 2020;5:9.

Article  PubMed  PubMed Central  Google Scholar 

Geck RC, Boyle G, Amorosi CJ, Fowler DM, Dunham MJ. Measuring pharmacogene variant function at scale using multiplexed assays. Annu Rev Pharmacol Toxicol. 2021;62:531–50.

Article  PubMed  Google Scholar 

Cheng J, Novati G, Pan J, Bycroft C, Žemgulytė A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381(6664):eadg7492.

Article  CAS  PubMed  Google Scholar 

Morris SA, Alsaidi AT, Verbyla A, Cruz A, Macfarlane C, Bauer J, et al. Cost effectiveness of pharmacogenetic testing for drugs with clinical pharmacogenetics implementation consortium (CPIC) guidelines: a systematic review. Clin Pharmacol Ther. 2022;112(6):1318–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang G, Nebert DW. Personalized medicine: Genetic risk prediction of drug response. Pharmacol Ther. 2017;175:75–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nebert DW, Zhang G. Pharmacogenetics and pharmacogenomics. Emery Rimoin’s Princ Pract Med Genet. 2019;16:445–86.

Google Scholar 

Yengo L, Vedantam S, Marouli E, Sidorenko J, Bartell E, Sakaue S, et al. A saturated map of common genetic variants associated with human height. Nature. 2022;610(7933):704–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miga KH, Eichler EE. Envisioning a new era: complete genetic information from routine, telomere-to-telomere genomes. Am J Hum Genet. 2023;110(11):1832–40.

Article  CAS  PubMed